Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.

Autor: Hiranuma K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan., Asami Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan., Kato MK; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan., Murakami N; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan., Shimada Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Matsuda M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yazaki S; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Fujii E; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kuno I; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan., Komatsu M; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan., Makinoshima H; Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan., Matsumoto K; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan., Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Terao Y; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan., Itakura A; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan., Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.

Publikováno v: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17835-17848. Date of Electronic Publication: 2023 Aug 03.

Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.

Autor: Nishikawa T; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Otsuka T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuno I; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Kukita Y; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Nakamura H; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Ikeda Y; Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan., Yasui T; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Shioyama W; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Oka T; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Honma K; Department of Pathology, Osaka International Cancer Institute, Osaka, Japan., Hatakeyama K; Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan., Miyata H; Department of Surgery, Osaka International Cancer Institute, Osaka, Japan., Isei T; Department of Dermatological Oncology, Osaka International Cancer Institute, Osaka, Japan., Ishihara R; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan., Fujita M; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan.

Publikováno v: PloS one [PLoS One] 2022 Nov 15; Vol. 17 (11), pp. e0275865. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).

Urethral metastasis from esophageal cancer: symptoms of dysuria and cystoscopic diagnosis.

Autor: Kitashiro S; Department of Medical Oncology, Yodogawa Christian Hospital, Osaka, Japan., Kuno I; Department of Medical Oncology, Yodogawa Christian Hospital, Osaka, Japan., Sugano T; Department of Diagnostic Pathology, Yodogawa Christian Hospital, Osaka, Japan., Yamano Y; Department of Urology, Yodogawa Christian Hospital, Osaka, Japan., Shigeoka Y; Department of Medical Oncology, Yodogawa Christian Hospital, Osaka, Japan., Inaba M; Department of Diagnostic Pathology, Yodogawa Christian Hospital, Osaka, Japan.

Publikováno v: Oxford medical case reports [Oxf Med Case Reports] 2022 Sep 26; Vol. 2022 (9), pp. omac099. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

Autor: Murakami N; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Kuno I; Department of Gynecologic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Kato T; Department of Gynecologic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Igaki H; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.

Publikováno v: Journal of radiation research [J Radiat Res] 2022 Mar 17; Vol. 63 (2), pp. 312-313.

INFLUENCE OF PHASE TRANSITIONS ON THE TEMPERATURE BEHAVIOR OF PHOTOLUMINESCENCE SPECTRA IN A (N(CH3)4)2MnCl4 CRYSTAL.

Autor: Ilchuk, H., Kashuba, A., Kuno, I., Sveleba, S., Malyi, T., Petrus, R., Tsiumra, V., Semkiv, I.

Publikováno v: Eastern-European Journal of Enterprise Technologies; 2020, Vol. 106 Issue 12, p24-30, 7p